Reuters logo
2 个月前
BRIEF-Gemphire Therapeutics reports departure of CEO
2017年5月30日 / 晚上8点17分 / 2 个月前

BRIEF-Gemphire Therapeutics reports departure of CEO

1 分钟阅读

May 30 (Reuters) - Gemphire Therapeutics:

* Gemphire Therapeutics announces departure of its chief executive officer Mina Sooch

* Gemphire Therapeutics Inc- ‍steven Gullans named interim president and chief executive officer until a search for his replacement is completed​

* Gullans is managing director at excel Venture Management, Llc, which owns more than 5 pct of Gemphire's outstanding stock Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below